Almutwinterstein

The study examines the prevalence and factors associated with the long-term concurrent use of stimulants and opioids among adults with ADHD.

Winterstein is one of four UF College of Pharmacy faculty members named as UF Term Professors.

The nearly $3 million grant will enhance the FDA’s capability to conduct drug safety studies on maternal and infant outcomes involving exposure to medications during pregnancy.

The paper authored by researchers in the department of pharmaceutical outcomes and policy won the University of Florida College of Pharmacy’s 2018 Best Clinical Research Paper Award.

The grant from the Bill & Melinda Gates Foundation will help prevent unintended pregnancies.

The American Journal of Health-Systems Pharmacy highlights Winterstein’s research on developing prediction models for preventable adverse drug events in hospitals.

Pictured are Dr. Winterstein and Dr. David Norton, vice president for research at the University of Florida, at the Oct. 11 luncheon.

Researchers in the UF College of Pharmacy determined that a child’s age when diagnosed with ADHD may be a strong predictor of the types and number of medications that are later prescribed to treat psychiatric conditions.

Graduate student Juan Hincapie-Castillo, Pharm.D., researched the prevalence of psychotherapy among Medicaid-insured patients within six months of initiating psychotropic medication polypharmacy.

Dr. Winterstein is one of 34 UF faculty members to receive a University of Florida Research Foundation Professorship for 2017-2020.